Literature DB >> 23940429

Comparison of the diagnostic accuracy of ischemia-modified albumin and echocardiography in patients with acute chest pain.

Evangelia Kountana1, Konstantinos Tziomalos, Panagiotis Semertzidis, Fani Dogrammatzi, Aristidis Slavakis, Stella Douma, Chrysanthos Zamboulis, Paraschos Geleris.   

Abstract

BACKGROUND: Several imaging tests and biomarkers have been proposed for the identification of patients with unstable angina among those presenting to the emergency department with acute chest pain. Preliminary data suggest that ischemia-modified albumin (IMA) may represent a potentially useful biomarker in these patients.
OBJECTIVE: To compare IMA and echocardiography in excluding unstable angina in patients with acute chest pain.
METHODS: Thirty-three patients (mean [± SD] age 59.8±10.8 years; 28 men) presenting to the emergency department with acute chest pain lasting <3 h suggestive of acute coronary syndrome, with normal or non-diagnostic electrocardiograms, and creatine kinase MB and troponin levels within the normal range, were included in the present study.
RESULTS: After further diagnostic evaluation, five patients (15.2%) were diagnosed with unstable angina. The sensitivity, specificity, positive predictive value and negative predictive (NPV) value of echocardiography for diagnosing unstable angina was 60.0%, 89.3%, 50.0% and 92.6%, respectively. The area under the ROC curve for diagnosing unstable angina based on the serum IMA levels was 0.193 (95% CI 0.047 to 0.339; P<0.05). Based on ROC curve analysis, serum IMA levels ≥31.95 IU/mL yielded the optimal combination of sensitivity and specificity for diagnosing unstable angina. The sensitivity, specificity, positive predictive value and NPV of serum IMA levels ≥31.95 IU/mL for diagnosing unstable angina was 40.0%, 28.6%, 9.1% and 72.7%, respectively.
CONCLUSIONS: Measurement of serum IMA levels appears to represent a useful tool for excluding unstable angina in patients presenting to the emergency department with acute chest pain. Moreover, IMA shows an NPV that is comparable with echocardiography.

Entities:  

Keywords:  Acute chest pain; Acute coronary syndromes; Echocardiography; Ischemia-modified albumin; Unstable angina

Year:  2013        PMID: 23940429      PMCID: PMC3718584     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  17 in total

1.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

2.  Diagnostic accuracy and prognostic value of dobutamine stress myocardial contrast echocardiography in patients with suspected acute coronary syndromes.

Authors:  Jeane M Tsutsui; Feng Xie; Edward L O'Leary; Abdou Elhendy; James R Anderson; Anna C McGrain; Thomas R Porter
Journal:  Echocardiography       Date:  2005-07       Impact factor: 1.724

3.  Prospective evaluation of the clinical application of the American College of Cardiology Foundation/American Society of Echocardiography Appropriateness Criteria for transthoracic echocardiography.

Authors:  R Parker Ward; Ibrahim N Mansour; Nicole Lemieux; Nitin Gera; Rupa Mehta; Roberto M Lang
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

4.  Importance of two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms.

Authors:  P Sabia; R D Abbott; A Afrookteh; M W Keller; D A Touchstone; S Kaul
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

5.  Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department.

Authors:  Frank Peacock; Deborah L Morris; Saif Anwaruddin; Robert H Christenson; Paul O Collinson; Steve W Goodacre; James L Januzzi; Robert L Jesse; Juan C Kaski; Michael C Kontos; Guillaume Lefevre; Dave Mutrie; Manas K Sinha; Denise Uettwiller-Geiger; Charles V Pollack
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

6.  2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Alice K Jacobs
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

Review 7.  Clinical and analytical review of ischemia-modified albumin measured by the albumin cobalt binding test.

Authors:  Fred S Apple
Journal:  Adv Clin Chem       Date:  2005       Impact factor: 5.394

Review 8.  Chest pain centers: diagnosis of acute coronary syndromes.

Authors:  A B Storrow; W B Gibler
Journal:  Ann Emerg Med       Date:  2000-05       Impact factor: 5.721

Review 9.  Ischemia modified albumin: is this marker of ischemia ready for prime time use?

Authors:  Eftihia Sbarouni; Panagiota Georgiadou; Dimitrios Th Kremastinos; Vasilios Voudris
Journal:  Hellenic J Cardiol       Date:  2008 Jul-Aug

10.  Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.

Authors:  Nadhipuram V Bhagavan; Ernest M Lai; Patricia A Rios; Jinsheng Yang; Anna M Ortega-Lopez; Hiroko Shinoda; Stacey A A Honda; Carlos N Rios; Cheryl E Sugiyama; Chung-Eun Ha
Journal:  Clin Chem       Date:  2003-04       Impact factor: 8.327

View more
  3 in total

1.  Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.

Authors:  Amira Abdel Moneam Adly; Nayera Hazaa Khalil ElSherif; Eman Abdel Rahman Ismail; Yosra Abdelzaher Ibrahim; Gamal Niazi; Sara Hamed Elmetwally
Journal:  Redox Rep       Date:  2017-03-13       Impact factor: 4.412

Review 2.  Diagnostic Accuracy of Ischemia-Modified Albumin for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Hyungoo Shin; Jae-Guk Kim; Bo-Hyoung Jang; Tae-Ho Lim; Wonhee Kim; Youngsuk Cho; Kyu-Sun Choi; Min-Kyun Na; Chiwon Ahn; Juncheol Lee
Journal:  Medicina (Kaunas)       Date:  2022-04-28       Impact factor: 2.948

3.  Stronger correlation with myocardial ischemia of high-sensitivity troponin T than other biomarkers.

Authors:  Theodore Pipikos; Alkistis Kapelouzou; Diamantis I Tsilimigras; Yannis Fostinis; Marina Pipikou; Athanassios Theodorakos; Antonis N Pavlidis; Christos Kontogiannis; Dennis V Cokkinos; Maria Koutelou
Journal:  J Nucl Cardiol       Date:  2018-01-29       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.